Capturing the Chinese Market: Why Global Fertility Leaders Gather at CMTF

The global assisted reproductive technology (ART) market is witnessing a massive influx of Chinese intended parents seeking cross-border medical solutions. For international fertility clinics, surrogacy agencies, and reproductive tech companies, the China Medical Tourism Fair (CMTF) has become the definitive gateway to tap into this lucrative market.

While CMTF operates primarily as a highly efficient B2B matchmaking platform connecting global clinics with domestic agencies, it also provides a unique window to consult directly with a select group of high-net-worth B2C patients. By analyzing the specific, unmet needs of the Chinese market, it becomes clear why the world’s top reproductive enterprises prioritize CMTF to expand their channel networks and build brand trust.

Fair/ Conference/ Networking Dinner/ Award Ceremony

I. Inside the Core Demands of Chinese Fertility Patients

China’s domestic fertility market faces strict regulatory boundaries, creating a massive wave of outbound medical travel. The primary drivers that overseas clinics can capitalize on include:

  • Gender Selection & Family Balancing: Due to cultural traditions or a desire for family balancing, many families seek pre-implantation genetic testing (PGT-A/PGT-M) for sex selection. Since non-medical gender selection is strictly prohibited in China, couples rely on international clinics where the technology is legally accessible.

  • Surrogacy & Third-Party Reproduction: Commercial surrogacy and legal egg/sperm donation are unavailable in the Chinese mainland. This creates an unyielding demand among LGBTQ+ individuals, single intended parents, and couples facing severe medical infertility to seek legal third-party reproductive services overseas.

  • Social Egg Freezing (Fertility Preservation): Unmarried women in China are legally restricted from freezing their eggs for social reasons. As a result, professional single women are increasingly traveling abroad to freeze their eggs, safeguarding their future fertility options.

  • Advanced Maternal Age & Complex Cases: Facing declining ovarian reserves or multiple failed IVF cycles domestically, older couples seek premium overseas clinics equipped with world-class laboratories, innovative cell technologies, and customized rejuvenation protocols.

II. Why Global Reproductive Enterprises Choose CMTF

CMTF functions as a powerful catalyst for international fertility brands looking to establish a dominant foothold in China. The exhibition offers unmatched strategic value across both B2B and B2C dimensions:

  • Dominating the B2B Agency Ecosystem (Primary Focus): The vast majority of outbound Chinese IVF patients do not navigate the process alone; they rely heavily on local medical tourism agencies, health management centers, and high-end concierge services. CMTF gathers thousands of these regional intermediaries, giving overseas clinics a one-stop platform to sign exclusive channel partnerships and build their domestic referral networks.

  • Direct B2C Trust Building with HNWIs: High-net-worth individuals (HNWIs) seeking premium fertility care often attend CMTF to bypass intermediaries and evaluate clinics directly. For these patients, investing tens of thousands of dollars overseas requires absolute trust. CMTF allows global doctors to consult face-to-face with these families, breaking down language barriers and closing complex cases on-site.

  • Aligning with Cutting-Edge Industry Trends: CMTF is more than an exhibition; its concurrent forums explore the integration of reproductive medicine with regenerative therapies, precision nutrition, and AI-driven lab protocols, keeping exhibitors at the forefront of medical innovation.

III. Featured Global Reproductive Leaders at CMTF

CMTF consistently attracts an elite lineup of global reproductive clinics, laboratories, and supply chain partners. Notable recurring exhibitors include:

🇺🇸 United States

Renowned for its highly legal and mature third-party reproduction framework, top-tier laboratory standards, and advanced PGT-A technologies.

  • WFI (Western Fertility Institute)

  • INCITA (Incinta Fertility)

  • EFC (Ember Fertility Center)

  • HRC

  • SCRC (Southern California Reproductive Center)

  • CEF

  • Genprime

  • California Fertility Clinic

  • Saipan IVF

🇹🇭 Thailand

The premier destination for Asian patients due to geographical proximity, high success rates, excellent hospitality, and favorable policies for gender selection.

  • REP IVF Center

  • One Life Fertility

  • EVERLINK

  • Jetanin Hospital

  • Bumrungrad International Hospital (康民医院)

  • NIC IVF Center

  • GFC (Genesis Fertility Center)

  • BPK9

  • Superior ART

  • CMIVF

🇯🇵 Japan

Highly favored by Chinese patients for its specialized low-stimulation protocols tailored for advanced-age women and its meticulous laboratory craftsmanship.

  • TOKYO ART CLINIC

  • Hanaoka IVF (花冈IVF)

  • IMG MEDICAL GROUP

  • ihope Fertility Center

  • Morozumi Ladies Clinic(两角生殖)

  • Oak Clinic

🇷🇺 Russia

A popular European hub offering clear, legally protected third-party reproduction regulations and highly competitive package pricing.

  • NGC (Next Generation Clinic)

  • Nova Clinic

  • IVF Clinic Klinika+1

🇬🇪 Georgia

Emerging as a massive global hotspot for affordable, fully compliant legal surrogacy and egg donation frameworks for international heterosexual couples.

  • SILK medical

  • Beta Plus Fertility

  • GGRC (Georgian-German Reproductive Center)

  • Heri (Heri Fertility)

  • Sino Georgia IVF Center

  • REPROART

🌐 Other Leading Global Destinations

  • Kyrgyzstan:Tang IVF, Delta Fertility, Tulip Fertility

  • Kazakhstan: TEFIA IVF AGENCY, Miracle IVF, Angle Way

  • Dubai:Smart Fertility

  • Taiwan,China: Lee Women's Hospital, TAIPEI FERTILITY CENTER

  • Australia: Ausmed Travel, Niutes

  • Denmark: Cryos International

  • Mexico & Columbia: Power IVF, UCFC

The Momentum Continues

Thank you to all the global enterprises and regional partners who made this gathering a monumental success. If you missed the opportunity to connect with these reproductive industry leaders in Shanghai, our journey is far from over.

Join us at our upcoming stops and secure your booth today:

👉 Next Stop: July in Shenzhen

👉 Future Dates: November in Beijing | March in Chengdu

👉 Contact us for speaking/exhibiting: +86-13570219945 (Phone & Whatsapp& WeChat)

Next
Next

Global Medical Tourism Destination Insights: Hong Kong, China